methotrexate has been researched along with Devic Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 5 (83.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ishibashi, S; Kizawa, M; Ohkubo, T; Sanjo, N; Sato, N; Toide, N; Yokota, T | 1 |
Elsone, L; George, J; Jacob, A; Kitley, J; Leite, MI; Palace, J; Vincent, A; Waters, P; Woodhall, M | 1 |
Malhotra, K; Ramanathan, RS; Scott, T | 1 |
Chandratre, S; Halfpenny, C; Hemingway, C; Leite, MI; O'Brien, F; Palace, J; Rocha, J; Tackley, G; Wasiewski, W; Wassmer, E; Waters, P; Woodhall, M | 1 |
Beh, SC; Burns, D; Desena, A; Frohman, EM; Frohman, TC; Greenberg, B; Kildebeck, E; Narayan, R; Rowe, ES; Rowe, V; Schell, D; Whitworth, L | 1 |
Bergamaschi, R; Bogdanov, EI; Mikhaylov, IM; Moglia, A; Pichiecchio, A; Ravaglia, S | 1 |
6 other study(ies) available for methotrexate and Devic Disease
Article | Year |
---|---|
Methotrexate-associated lymphoproliferative disorder in a patient with neuromyelitis optica spectrum disorder: An implication for pathogenesis mediated by Epstein-Barr virus.
Topics: Adult; Epstein-Barr Virus Infections; Female; Humans; Lymphoproliferative Disorders; Methotrexate; Neuromyelitis Optica | 2017 |
Methotrexate is an alternative to azathioprine in neuromyelitis optica spectrum disorders with aquaporin-4 antibodies.
Topics: Adolescent; Adult; Aged; Antibodies; Aquaporin 4; Azathioprine; Child; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate.
Topics: Adult; Aged; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Neuromyelitis Optica; Retrospective Studies; Treatment Outcome | 2014 |
Neuromyelitis optica relapses: Race and rate, immunosuppression and impairment.
Topics: Adolescent; Adult; Age of Onset; Azathioprine; Black People; Disability Evaluation; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Least-Squares Analysis; Male; Methotrexate; Neuromyelitis Optica; Prospective Studies; Regression Analysis; Rituximab; Seasons; Severity of Illness Index | 2016 |
High-dose methotrexate with leucovorin rescue: For monumentally severe CNS inflammatory syndromes.
Topics: Adult; Brain; Disability Evaluation; Drug Repositioning; Drug Resistance; Female; Humans; Immunosuppressive Agents; Leucovorin; Male; Methotrexate; Middle Aged; Multiple Sclerosis; Neuromyelitis Optica; Retrospective Studies; Sjogren's Syndrome; Time Factors; Treatment Outcome | 2017 |
Pathogenetic role of myelitis for syringomyelia.
Topics: Adult; Back Pain; Female; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Methotrexate; Methylprednisolone; Multiple Sclerosis; Myelitis; Myelitis, Transverse; Neck Pain; Neurologic Examination; Neuromyelitis Optica; Paresthesia; Prednisone; Quadriplegia; Recurrence; Sarcoidosis; Spinal Cord; Syringomyelia | 2007 |